Some cells undergo apoptosis in response to DNA damage, while others do not. To understand the biochemical pathways controlling this differential response, we have studied the intracellular localization of cyclin B1 in cell types sensitive or resistant to DNA damage-induced apoptosis.
Introduction
DNA damage causes both cell cycle arrest and apoptosis 1 . However, the response to genotoxic stress varies between tissues and some cells rapidly undergo apoptosis in response to DNA damage while others do not. For example, hematopoietic cells undergo apoptosis after exposure to as little as 100-200cGy of γ-radiation 2; 3 whereas fibroblast-like cells are resistant to these doses 4; 5 . The biochemical basis for this difference has yet to be clearly established. In this report,
we have investigated the role that the cyclin B1 cell cycle regulator has in controlling the apoptotic response to γ-radiation. Cyclin B1 has important roles in both mitosis 6 and γ-radiationinduced apoptosis 7 .
B-type cyclins are binding partners of the cdc2 (cdk1) serine/threonine kinase 8 . The cyclin B/cdc2 heterodimer is referred to as the M-phase-promoting-factor (MPF) because of its ability to induce mitosis by phosphorylating and activating enzymes regulating chromatin condensation, nuclear membrane breakdown, and mitotic microtubule reorganization 9 . Of the B-type cyclins, B1
is likely to be most important in mitotic regulation since mice lacking cyclin B2 develop normally and are fertile, while mice lacking cyclin B1 die during embryonic development 10 . The kinase activity of the cyclin B1/cdc2 complex is regulated by the abundance of cyclin B, the association kinetics of cyclin B and cdc2, and by the phosphorylation state of cdc2 8 . In order for mitosis to proceed, an active cyclin B/cdc2 complex must also accumulate in the nucleus in late prophase 11 .
Nuclear accumulation of cyclin B1 at the onset of mitosis is dependent on phosphorylation within its cytoplasmic retention signal (CRS) 12; 13 . In Xenopus, cyclin B1 nuclear accumulation is controlled, at least in part, through phosphorylation by the Polo-like-kinase 14 . Phosphorylation of the CRS may enhance association with cyclin F or importin β, proteins that enhance nuclear import of cyclin B1 15; 16 . Alternatively, phosphorylation may decrease association with Crm1 17 , a nuclear exporter of cyclin B1.
Cyclin B1 is the target of multiple mitotic checkpoints. In human HeLa cells, DNA damage causes a decrease in cyclin B1 mRNA abundance, a decrease in cyclin B1 mRNA half-life, and an inhibition of cyclin B1 nuclear accumulation 18; 19 . The repression of cyclin B1 transcription is also one mechanism by which the p53 tumor suppressor inhibits G2/M transition 20 .
Cyclin B1 is a key regulator of apoptosis in some cell types. Cyclin B1 protein is both necessary and sufficient for the induction of γ-radiation-induced apoptosis in hematopoietic cells 7 .
Cyclin B1 accumulation is also involved in the apoptosis caused by NGF withdrawal 21 and T-cell receptor activation 22 . Because of the importance of cyclin B1-nuclear localization in mitosis, we have investigated the possibility that cyclin B1's nuclear accumulation may also be a key regulator in the cellular decision to undergo apoptosis in response to DNA damage. In this report, we have found that cyclin B1 rapidly accumulates in the nucleus in cells sensitive to γ-radiation-induced apoptosis, but not in the nucleus of cells resistant to radiation-induced apoptosis. Inhibition of CRM1, which leads to cyclin B1 nuclear accumulation, is sufficient to induce apoptosis in both the radiation-sensitive and -resistant cells. Furthermore, expression of a cyclin B1 protein that is predominantly nuclear (cyclin B1-5xE) is sufficient to induce apoptosis, while a cytoplasmic cyclin B1 allele (cyclin B1-5xA) is not capable of inducing apoptosis. This study provides evidence that localization of cyclin B1 is important in the cellular decision to undergo apoptosis in response to DNA damage. and propidium iodide were added to the cell suspensions on ice as specified by the manufacturer and incubated on ice in the dark for 10 minutes. Cell cycle profiles of no less than 20,000 cells were generated on a Coulter EPICS XL Profile flow cytometer. Data was collected and analyzed using Coulter Epics System II Software Version 3.0. Cells were irradiated using a calibrated Cesium 137 gamma cell irradiator (Nordica, Instruments). Staining for the suspension cell line Ramos and for primary thymocytes visualized by Zeist Axiovert 100M confocal system with both and argon ion 488nm line and a He-Ne 543 line.
0.5µM serial sections in the Z-axis of the cell were analyzed using LSM 510 software version 2.3.
Deconvolution microscopy was performed using a Leitz DM1RB and the computer program Open Lab (Improvision). We utilized confocal and fluorescence microscopy to determine whether there might be differences in the intracellular localization of cyclin B1 between apoptosis-sensitive and -resistant Because apoptosis involves breakdown of nuclear structures 26 , we wished to exclude the possibility that the apparent nuclear localization of cyclin B1 in irradiated Ramos cells might have resulted from cyclin B1 diffusing throughout a cell lacking an intact nucleus. To this end, we stained Ramos cells with an antibody specific for human lamins A and C, integral protein components of the nuclear lamina 27 . As shown in fig. 2C , irradiated Ramos cells maintain an intact lamin-staining ring (arrows) that contains cyclin B1 protein within it. On the other hand, 9 cyclin B1 protein in unirradiated Ramos cells do not show detectable cyclin B1 within the lamin ring. A higher magnification of a representative irradiated and unirradiated Ramos cells is shown in Fig 2D . This is consistent with the idea that cyclin B1 protein is indeed nuclear during the early stages of radiation-induced apoptosis.
For . Because only the radiation sensitive cells in fig. 1 showed evidence of radiation-induced cyclin B1 nuclear accumulation, we hypothesized that this difference might account for differences in radiation sensitivity. We reasoned that increasing cyclin B1 nuclear levels might itself be sufficient to sensitize the radiation-resistant cells. Nuclear accumulation of cyclin B1 is regulated in part by the CRM1 (exportin1) protein, which exports cyclin B1 from the nucleus into the cytoplasm 28; 29 . To determine whether nuclear accumulation of cyclin B1 might sensitize radiation-resistant cells we first determined whether the CRM1 inhibitor Leptomycin B (LMB) could trigger apoptosis in NIH3T3 cells. As shown in figure 3A , LMB treatment is sufficient to activate apoptosis, as measured by the large increase in Annexin staining. This dose of LMB is sufficient to cause nuclear accumulation of cyclin B1 ( fig.3B ). Because CRM1 has multiple cellular targets other than cyclin B1, we used cyclin B1 antisense to determine whether LMB-induced apoptosis required cyclin B1. As shown in figure 3C , cyclin B1 antisense, but not sense oligonucleotides inhibit LMB-induced apoptosis. Treatment with antisense inhibits cyclin B1 protein production in the presence and absence of LMB as determined by western blotting ( fig. 3D ). Control sense oligonucleotides had little effect on cyclin B1 protein levels. Antisense to cyclin A does not affect LMB-induced apoptosis ( fig 3E) but do decrease cyclin A, but not cyclin B protein levels ( fig 3F) . As shown in figure 3G , doses of LMB that do not induce appreciable apoptosis alone (0.05 ng/ml) sensitizes NIH3T3 cells to radiation-induced apoptosis. Similar results were also obtained with Cos-1 cells. This is consistent with the idea that modulating cyclin B1 nuclear levels through LMB can sensitize cells to radiation-resistant cells to radiation-induced apoptosis. As shown in figure 3H , LMB also induces apoptosis in Ramos cells. However, LMB induces apoptosis in Ramos cells at a dose 500 times less than in NIH 3T3 cells. Nuclear, but not cytoplasmic forms of cyclin B1 induce apoptosis. To determine directly if accumulation of cyclin B1 in the nucleus is sufficient to induce apoptosis, we utilized cyclin B1∆151, a cyclin B1 variant that is expressed predominantly in the nucleus 13 . Cyclin B1∆151 lacks the amino-terminal 151 amino acids and the CRS, but is able to bind cdc2 and form a functional cyclin B/cdc2 complex 13 . As shown in figure 4A , NIH3T3 cells transfected with cyclin B1∆151 become apoptotic relative to control cells transfected with the empty myc-tag vector. As shown in fig 4B, cyclin B1∆151 is expressed predominantly in the nucleus. Nuclear accumulation of cyclin B1 is regulated, at least in part, by the phosphorylation state of 5 serine residues (Ser116; Ser126; Ser128; Ser133; Ser147) within the CRS. Phosphorylation of the serines enhances nuclear accumulation 28 . To determine whether nuclear localization of cyclin B1 is necessary for apoptosis, we made use of two altered cyclin B1 alleles: cyclinB-5xA, where the CRS serine resides have been altered to non-phosphorylatable alanines and cyclinB5xE, where the CRS serine residues have been altered to phospho-mimetic glutamic acid 28 . Both cyclinB-5xA and cyclinB-5xE are GFP (green fluorescent protein) tagged at the amino-terminus 
Discussion.
We have found that hematopoietic cells (primary mouse thymocytes and Ramos human B cells)
undergoing γ-radiation-induced apoptosis accumulate cyclin B1 in their nucleus. Increasing nuclear cyclin B1 levels in these cells with Leptomycin B induces apoptosis, suggesting that nuclear accumulation of cyclin B1 is itself a signal for apoptotic initiation. Cyclin B1 is the regulatory subunit of the cdc2 kinase and other groups have previously found that cdc2 activation is required for the apoptosis induced by Granzyme B, T-cell activation, and multiple anti-cancer agents 22; 30; 31 . However, cdc2 activation is not necessary for all forms of apoptosis [32] [33] [34] .
Thus, it is likely that some pathways of apoptosis require cyclin B1/cdc2 while others do not.
Our data is consistent with the idea that cyclin B1 is involved in DNA damage-induced apoptosis.
We find that cells sensitive to γ-radiation-induced apoptosis accumulate cyclin B1 in their nucleus while apoptosis-resistant cells do not. Inducing nuclear cyclin B1 accumulation with LMB sensitizes these cells to radiation-induced apoptosis. This observation is consistent with the idea that differential cytoplasmic localization of cyclin B1 may be why some cell types, generally hematopoietic cell types, readily undergo apoptosis to DNA damage while others, generally epithelial cells, do not. Exclusion of cyclin B1 from the nucleus and inactivation of cyclin B1/cdc2 kinase activity in response to DNA damage causes a G2/M arrest allowing DNA repair 18; 19 . It is possible that apoptosis-sensitive cells lack the biochemical mechanism(s) that prevent cyclin B1 from entering the nucleus following DNA damage. Resistant cells are capable of undergoing apoptosis when transfected with nuclear-specific isoforms of cyclin B1 or when treated with LMB. Thus, these cells remain competent for apoptosis induction by nuclear cyclin B1.
We find that in addition to sensitizing cells to DNA damage-induced apoptosis, LMB is itself capable of inducing apoptosis. We observed that cyclin B1 antisense prevents LMB from inducing apoptosis in NIH 3T3 cells. This suggests that though CRM1 controls the nuclear export of multiple proteins, cyclin B1 is likely to be the important CRM1 target for apoptosis.
The ability of LMB to sensitize NIH 3T3 cells to radiation-induced apoptosis suggests that this fungal metabolite may find use as a anti-cancer agent in conjunction with other apoptosis-inducing stimuli. Leptomycin B1 has anti-tumor activity against some solid tumors xenografted into mice 35 , but it has yet to be tried in vivo with radiation or chemo-therapeutic drugs. Because cyclin B1 is critical in controlling the mitosis in normal cells, LMB islikely to have some toxicity in normal cells, a characteristic that LMB would share with other chemotherapeutics,. However, it is possible that a rapidly proliferating tumour cell may display more sensitivity to LMB that normal quiescent cells due to the increased abundance of total cyclin B1 in an actively proliferating cell population. This idea remains to be tested but LMB could hold some promise as strategy for anti-cancer therapy.
The mechanisms by which nuclear localization of cyclin B1 in apoptosis-sensitive cells leads to apoptosis is unclear. Because the polo-like-kinase is important in controlling cyclin B1
nuclear accumulation during mitosis in Xenopus 14 , it may also be involved in regulating DNAdamage-induced apoptosis. Since nuclear accumulation of cyclin B1 is a trigger for mitosis, it is possible that DNA damage-induced cyclin B1 nuclear accumulation may lead to apoptosis through an inappropriate triggering of mitosis 36 . Cyclin B1/cdc2 could affect that apoptotic machinery directly or apoptosis may proceed through entry into a G2/M like cell state. Since sensitivity to DNA damage-induced apoptosis controls the efficacy of many anti-cancer therapies 37 , it is important to elucidate the biochemical pathways that govern cyclin B1 nuclear localization in radiation sensitive and resistant cells. 
